Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets OTCPK - Delayed Quote USD

BioSyent Inc. (BIOYF)

7.69
+0.12
+(1.59%)
At close: April 25 at 4:00:00 PM EDT
Currency in CAD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
35,030.90
35,030.90
31,590.30
27,925.19
28,618.22
Cost of Revenue
7,174.82
7,174.82
5,992.36
5,067.30
5,980.36
Gross Profit
27,856.07
27,856.07
25,597.94
22,857.88
22,637.86
Operating Expense
18,791.75
18,791.75
18,063.69
15,951.04
14,390.23
Operating Income
9,064.32
9,064.32
7,534.25
6,906.84
8,247.63
Net Non Operating Interest Income Expense
1,029.43
1,029.43
1,062.71
448.65
51.80
Other Income Expense
-311.26
-311.26
-63.11
75.16
78.99
Pretax Income
9,782.50
9,782.50
8,533.85
7,430.65
8,378.42
Tax Provision
2,512.39
2,512.39
2,073.73
1,972.31
2,096.86
Net Income Common Stockholders
7,270.10
7,270.10
6,460.13
5,458.35
6,281.57
Diluted NI Available to Com Stockholders
7,270.10
7,270.10
6,460.13
5,458.35
6,281.57
Basic EPS
0.61
0.64
0.54
0.44
0.49
Diluted EPS
0.60
0.64
0.53
0.43
0.49
Basic Average Shares
11,662.77
11,369.66
11,949.90
12,303.12
12,689.16
Diluted Average Shares
11,881.72
11,369.66
12,170.41
12,540.64
12,871.28
Total Operating Income as Reported
8,753.06
8,753.06
7,471.14
6,982
8,183.20
Total Expenses
25,966.58
25,966.58
24,056.05
21,018.35
20,370.59
Net Income from Continuing & Discontinued Operation
7,270.10
7,270.10
6,460.13
5,458.35
6,281.57
Normalized Income
7,501.42
7,501.42
6,507.90
5,403.14
6,316.06
Interest Income
1,088.59
1,088.59
1,131.12
525.80
137.05
Interest Expense
59.15
59.15
68.41
77.14
85.25
Net Interest Income
1,029.43
1,029.43
1,062.71
448.65
51.80
EBIT
9,841.65
9,841.65
8,602.26
7,507.79
8,463.67
EBITDA
10,431.60
10,431.60
9,057.60
7,958.79
8,920.77
Reconciled Cost of Revenue
7,174.82
7,174.82
5,992.36
5,067.30
5,980.36
Reconciled Depreciation
589.95
589.95
455.34
451
457.11
Net Income from Continuing Operation Net Minority Interest
7,270.10
7,270.10
6,460.13
5,458.35
6,281.57
Total Unusual Items Excluding Goodwill
-311.26
-311.26
-63.11
75.16
-46.01
Total Unusual Items
-311.26
-311.26
-63.11
75.16
-46.01
Normalized EBITDA
10,742.85
10,742.85
9,120.72
7,883.63
8,966.78
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-79.94
-79.94
-15.34
19.95
-11.51
12/31/2021 - 2/22/2012

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CPHRF Cipher Pharmaceuticals Inc.
8.95
+3.47%
 
VP4.F Vistin Pharma ASA
2.1000
+5.79%
 
SBBCF Simply Better Brands Corp.
0.6104
0.00%
 
CPH.TO Cipher Pharmaceuticals Inc.
12.40
+3.33%
 
HROW Harrow, Inc.
25.55
+1.91%
 
LOVE.V Cannara Biotech Inc.
1.4000
+1.45%
 
AYTU Aytu BioPharma, Inc.
1.1100
+0.91%
 
LNTH Lantheus Holdings, Inc.
101.77
-1.80%
 
CRON Cronos Group Inc.
1.8000
-2.70%
 
ESPR Esperion Therapeutics, Inc.
0.9200
+4.39%